CTOR

Citius Oncology, Inc. CTOR

CTOR
Citius Oncology, Inc. TVGN
Tevogen Bio Holdings Inc. RPID
Rapid Micro Biosystems, Inc. LNSR
LENSAR, Inc. RCEL
AVITA Medical, Inc. ATOS
Atossa Therapeutics, Inc. ABOS
Acumen Pharmaceuticals, Inc. CCCC
C4 Therapeutics, Inc. MOLN
Molecular Partners AG GLSI
Greenwich LifeSciences, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CTOR TVGN RPID LNSR RCEL ATOS ABOS CCCC MOLN GLSI
6M 173.75 % -24.75 % 35.68 % -14.07 % -56.15 % 53.88 % 91.51 % 69.29 % 3.98 % 1.61 %
YTD 42.86 % -33.81 % 213.29 % 36.36 % -68.80 % 2.03 % 9.73 % -35.25 % -19.51 % -19.17 %
1Y 37.10 % -59.21 % 247.63 % 116.64 % -62.46 % -32.44 % -29.02 % -62.68 % -19.51 % -29.86 %
3Y -85.13 % -93.09 % -4.35 % 113.51 % -17.39 % 20.94 % -74.75 % -74.35 % -37.28 % -4.33 %
5Y -85.13 % -92.94 % -85.61 % 34.81 % -83.14 % -51.02 % -89.90 % -90.92 % -80.05 % 106.30 %
10Y -85.13 % -92.94 % -85.61 % 31.67 % -54.92 % -99.27 % -89.90 % -90.70 % -80.05 % 89.80 %
From the beginning -85.13 % -92.94 % -85.61 % 31.67 % -84.04 % -99.89 % -89.90 % -90.70 % -80.05 % 89.80 %

Dividend